SOD2 Mouse

Superoxide Dismutase-2 Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

SOD2 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 221 amino acids (25-222 a.a) and having a molecular mass of 24.6kDa.
SOD2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Superoxide dismutase 2 (SOD2) is an enzyme that plays a crucial role in protecting cells from oxidative stress. It is a member of the iron/manganese superoxide dismutase family and is localized in the mitochondria, where it converts superoxide radicals produced during oxidative phosphorylation into hydrogen peroxide and oxygen. SOD2 deficiency has been linked to various diseases, including heart disease, neurodegenerative disorders, and cancer.
Description
This product is a recombinant SOD2 protein produced in E. coli. It is a single, non-glycosylated polypeptide chain with a molecular weight of 24.6 kDa. The protein consists of 221 amino acids (residues 25-222) and has a 23 amino acid His-tag at the N-terminus for purification. It is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile solution.
Formulation
The SOD2 protein is supplied in a solution containing 1 mg/ml protein, phosphate-buffered saline (pH 7.4), 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For longer storage, it is recommended to store the protein at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freezing and thawing.
Purity
The purity of the SOD2 protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Superoxide dismutase [Mn], Superoxide Dismutase-2, mitochondrial, Sod-2.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MGSKHSLPDL PYDYGALEPH INAQIMQLHH SKHHAAYVNN LNATEEKYHE ALAKGDVTTQ VALQPALKFN GGGHINHTIF WTNLSPKGGG EPKGELLEAI KRDFGSFEKF KEKLTAVSVG VQGSGWGWLG FNKEQGRLQI AACSNQDPLQ GTTGLIPLLG IDVWEHAYYL QYKNVRPDYL KAIWNVINWE NVTERYTACK K.

Q&A

What are the main types of SOD2 mouse models available for research?

Several SOD2 mouse models have been developed to study the role of this crucial mitochondrial enzyme in various physiological and pathological processes. The primary models include:

  • Germline Sod2 knockout mice (Sod2-/-): These mice have complete deletion of the Sod2 gene and do not survive beyond 10-21 days after birth due to multi-organ dysfunction, with the precise timing depending on genetic background .

  • Heterozygous Sod2 mice (Sod2+/-): These mice have approximately 50% reduced MnSOD activity in all tissues throughout life, making them valuable for studying chronic mild oxidative stress .

  • Conditional tissue-specific Sod2 knockout mice: These include inducible motor neuron-specific Sod2 knockout (i-mn-Sod2 KO) mice and osteocyte-specific knockouts (Dmp1-Sod2-/-) .

  • SOD2 overexpression models: Transgenic mice expressing the human mitochondrial superoxide dismutase 2 gene, created using P1 artificial chromosome (PAC) technology .

These models provide diverse platforms for studying the role of oxidative stress in development, aging, neurodegeneration, cancer, and other pathological conditions.

How do germline Sod2-/- mice differ phenotypically from conditional knockout models?

Germline Sod2-/- mice exhibit severe and lethal phenotypes that contrast markedly with conditional knockout models:

  • Germline Sod2-/- mice: These mice die within 1-18 days after birth with phenotypes including dilated cardiomyopathy or neurodegeneration depending on genetic background. They may present with small size, pale appearance, hypotonia, hypothermia, metabolic acidosis, lipid accumulation in liver and skeletal muscle, anemia, and CNS neuronal degeneration .

  • Conditional knockouts (e.g., i-mn-Sod2 KO): These mice develop phenotypes more gradually and in a tissue-specific manner. For example, i-mn-Sod2 KO mice show normal development initially, but by 8 months of age exhibit neurological dysfunction including motor coordination deficits. Neurological deficits manifest approximately two months after Sod2 deletion, with hindlimb paralysis developing by five months post-deletion .

  • Tissue-specific knockouts (e.g., Dmp1-Sod2-/-): These exhibit highly specific phenotypes such as bone loss and fragility in an age-dependent manner, with disorganized bone canaliculi in cortical bones, indicating osteocyte dysfunction .

The conditional models overcome the neonatal lethality limitation of the germline knockouts, enabling investigation of SOD2 function in specific tissues during adulthood.

What induction methods are used for conditional Sod2 knockout mice and what are their comparative advantages?

The most common induction method for conditional Sod2 knockout mice is the tamoxifen-inducible Cre-loxP system, as exemplified in the i-mn-Sod2 KO model:

  • Tamoxifen-inducible Cre-loxP system: This approach involves crossing Sod2 floxed mice with a tamoxifen-inducible neuronal-specific Cre mouse (e.g., SLICK-H Cre driven by the Thy1 promoter). Sod2 deletion is then induced by tamoxifen injection at the desired age (e.g., 2-3 months in the case of i-mn-Sod2 KO mice) .

  • Tissue-specific promoters: For non-inducible tissue-specific knockouts, promoters specific to target cells are used, such as the Dmp1 promoter for osteocyte-specific deletion .

Advantages of inducible systems:

  • Temporal control over gene deletion, allowing normal development before inducing knockout

  • Ability to study gene function in adult animals, avoiding developmental compensation

  • Possibility to create age-related disease models

  • Avoidance of neonatal lethality seen with germline knockouts

The choice between inducible and constitutive tissue-specific knockout depends on research objectives - inducible systems are preferred when studying acute effects of gene deletion or when avoiding developmental compensation is crucial.

How should superoxide levels be measured in SOD2 mouse models?

Based on established methodologies, superoxide levels in SOD2 mouse models can be measured using the dihydroethidium (DHE) assay:

  • DHE fluorescence assay: This method relies on the superoxide-induced conversion of DHE to ethidium, which emits detectable fluorescence. The procedure includes:

    • Isolating mitochondria from tissues of interest

    • Incubating mitochondria with DHE under specific conditions (e.g., with succinate and with/without rotenone)

    • Monitoring the increase in ethidium-emitted fluorescence over time

    • Using antimycin A as a positive control to enhance mitochondrial superoxide generation

    • Validating specificity by adding recombinant SOD to confirm superoxide-dependent signals

  • Experimental validation: Chemical validation can be performed using xanthine plus xanthine oxidase systems to generate superoxide in the presence of DHE, followed by SOD addition to confirm specificity .

  • Specific conditions for detection: To promote superoxide generation, mitochondria can be incubated under reverse electron flow conditions (presence of succinate without rotenone) .

This methodological approach provides a reliable measure of mitochondrial superoxide release rates and can be used to compare different SOD2 mouse models or assess interventions targeting oxidative stress.

How can motor function deficits be comprehensively evaluated in i-mn-Sod2 KO mice?

Motor function deficits in i-mn-Sod2 KO mice can be evaluated through a comprehensive battery of behavioral and physiological tests:

  • Open field test: This assesses locomotion and anxiety. Key parameters to measure include:

    • Total distance traveled (significantly reduced in i-mn-Sod2 KO mice)

    • Duration of immobility episodes (longer in i-mn-Sod2 KO mice)

    • Number of immobility episodes

    • Average speed of movement (decreased in i-mn-Sod2 KO mice)

  • Motor coordination tests: These should include assessment of:

    • Tail atony

    • Gait abnormality

    • Hind limb clasping

    • Progression to paralysis

  • Nerve conduction velocity (NCV): Sciatic nerve conduction velocity measurements can detect peripheral nerve dysfunction. Changes in NCV correlate with onset of paralysis in i-mn-Sod2 KO mice .

  • Visual acuity assessment: This is relevant as decreased visual acuity has been reported in these models .

The comprehensive approach should document the timeline of symptom progression, noting that neurological deficits typically manifest approximately two months after Sod2 deletion, with hindlimb paralysis developing by five months post-deletion in i-mn-Sod2 KO mice.

How do Sod2+/- mice compare to wild-type mice in terms of aging and cancer incidence?

Sod2+/- mice show fascinating differences from wild-type mice regarding cancer incidence but remarkably similar aging patterns:

Cancer incidence:

  • Tumor-bearing mice: 83% in Sod2+/- vs. 41% in wild-type mice

  • Mice with multiple tumors: 67% in Sod2+/- vs. 18% in wild-type mice

  • Specific tumor types show different patterns:

Tumor TypeWild-typeSod2+/-
Lymphoma22%61%*
Hemangioma0%11%
Adenocarcinoma0%6%
Pituitary adenoma33%28%

*Statistically significant (P<0.01)

Interestingly, while lymphoma incidence was dramatically increased in Sod2+/- mice, the severity of lymphoma and proliferative activity (measured by PCNA-positive cells) was similar between Sod2+/- and wild-type mice .

Aging parameters:
Despite the increased cancer incidence, several aging-related parameters were identical between Sod2+/- and wild-type mice:

  • Life span (mean and maximum survival)

  • Biomarkers of aging such as cataract formation

  • Immune response

  • Formation of glycoxidation products (carboxymethyl lysine and pentosidine) in skin collagen

This suggests that while chronic moderate oxidative stress increases cancer susceptibility, it may not necessarily accelerate the aging process itself.

What DNA damage patterns are observed in Sod2+/- mice and how do they change with age?

Sod2+/- mice exhibit specific patterns of oxidative DNA damage that increase with age:

  • 8-oxo-2-deoxyguanosine (8oxodG) levels: This marker of oxidative DNA damage is significantly elevated in all tissues of Sod2+/- mice compared to wild-type mice. The damage affects both nuclear and mitochondrial DNA .

  • Age-dependent increase: The levels of 8oxodG in nuclear DNA increase with age in all tissues of both Sod2+/- and wild-type mice, but at 26 months of age, the levels are significantly higher in Sod2+/- mice .

  • Tissue-specific differences: The age-related increase in 8oxodG varies by tissue:

    • Heart: approximately 15% higher in Sod2+/- mice compared to wild-type at 26 months

    • Liver: over 60% higher in Sod2+/- mice compared to wild-type at 26 months

    • Mitochondrial DNA in liver and brain also shows higher 8oxodG levels in Sod2+/- mice

This progressive accumulation of oxidative DNA damage likely contributes to the increased cancer incidence observed in Sod2+/- mice, supporting the connection between chronic oxidative stress and genomic instability.

What inflammatory and immune responses are associated with SOD2 deficiency in the nervous system?

SOD2 deficiency in neurons triggers specific inflammatory and immune responses in the nervous system:

  • Inflammatory response: i-mn-Sod2 KO mice exhibit increased inflammatory responses in the central nervous system, with phenotypes resembling certain aspects of multiple sclerosis (MS) .

  • Immune cell infiltration: There is evidence of immune cell infiltration in the central nervous system of i-mn-Sod2 KO mice, particularly:

    • Neutrophil infiltration in the spinal cord, which is notable as neutrophils are involved in driving pathology in experimental autoimmune encephalomyelitis (EAE) models and high neutrophil signatures have been associated with progressive forms of MS

    • Interestingly, T cell numbers in the CNS of i-mn-Sod2 KO mice are similar to control mice, suggesting T cells are not major contributors to the neuropathology in this model

  • Demyelination: Loss of myelination is observed in both central and peripheral nerves. Peripheral nerve involvement is particularly interesting as it parallels recent findings in MS showing that peripheral nerves can also be dysfunctional in this disease .

These inflammatory and immune responses suggest that neuronal oxidative stress may be an initiating factor in certain neurodegenerative and neuroinflammatory conditions, potentially providing insight into disease mechanisms and therapeutic targets.

How do SOD2 mouse models compare with other oxidative stress models for studying neurodegenerative diseases?

SOD2 mouse models offer distinct advantages and limitations compared to other oxidative stress models:

  • Comparison with EAE (Experimental Autoimmune Encephalomyelitis) models:

    • Similarities: Both i-mn-Sod2 KO mice and EAE models show tail atony, gait abnormality, hind limb clasping, paralysis, and decreased visual acuity

    • Key differences: Disease progression timeline varies significantly—EAE manifests within two weeks after induction with full paralysis by week three, while i-mn-Sod2 KO mice develop neurological deficits two months after Sod2 deletion with hindlimb paralysis by five months post-deletion

    • Mechanistic differences: EAE is primarily driven by adaptive immune responses, while i-mn-Sod2 KO pathology appears driven more by innate immunity (neutrophils) rather than T cells

  • Advantages of SOD2 models:

    • Cell-autonomous effects of oxidative stress can be studied

    • Both central and peripheral demyelination can be examined, making i-mn-Sod2 KO mice potentially valuable for studying MS states with both central and peripheral involvement

    • The progressive nature of symptoms more closely mimics human neurodegenerative disease compared to acute toxin models

  • Complementary approaches: For comprehensive understanding of oxidative stress in neurodegeneration, SOD2 models should be used alongside other approaches such as:

    • Pharmacological models (MPTP, rotenone)

    • Other genetic models targeting alternative components of redox systems

    • Combined genetic-environmental models that may better replicate human disease complexity

What molecular mechanisms explain the different phenotypes between various SOD2 mouse models?

The diverse phenotypes observed across different SOD2 mouse models can be explained by several molecular mechanisms:

  • Degree of SOD2 deficiency:

    • Complete knockout (Sod2-/-): Severe phenotypes with neonatal lethality due to complete loss of protection against mitochondrial superoxide

    • Heterozygous (Sod2+/-): Intermediate phenotype with increased oxidative damage but normal lifespan, suggesting compensatory mechanisms can manage ~50% reduction in activity

    • Conditional knockouts: Tissue-specific effects that depend on the metabolic demands and antioxidant capacity of affected tissues

  • Tissue-specific vulnerability:

    • Neurons are particularly vulnerable to oxidative stress due to being postmitotic, having high energy demands, and containing high concentrations of polyunsaturated fatty acids in their membranes that are susceptible to oxidation

    • Osteocytes show specific responses to SOD2 deficiency, with upregulation of Sost and Rankl genes that disrupt bone homeostasis

  • Compensatory mechanisms:

    • Overexpression models demonstrate reduced superoxide release rates under reverse electron flow conditions, confirming functional compensation

    • In heterozygous models, despite increased oxidative damage, aging biomarkers remain unaffected, suggesting activation of compensatory pathways specific to aging processes but not cancer prevention

  • Developmental timing:

    • Germline knockouts affect development from conception

    • Inducible models allow normal development before inducing deficiency, revealing functions that might be masked by developmental compensation or lethality

Understanding these mechanisms helps researchers select the most appropriate SOD2 mouse model for specific research questions and interpret results in the context of human disease.

How can i-mn-Sod2 KO mice be utilized as a model for multiple sclerosis research?

The i-mn-Sod2 KO mouse model offers unique advantages for multiple sclerosis (MS) research:

  • Phenotypic similarities to MS: These mice develop several features that parallel MS pathology:

    • Progressive motor deficits

    • Inflammatory responses in the central nervous system

    • Demyelination in both central and peripheral nervous systems

    • Immune cell infiltration, particularly neutrophils

  • Research applications:

    • Studying neurodegeneration-initiated MS: Unlike EAE models where immune attack triggers demyelination, i-mn-Sod2 KO mice represent a model where neuronal dysfunction (oxidative stress) may trigger subsequent inflammation and demyelination, potentially modeling primary progressive MS forms

    • Peripheral nerve involvement: These mice provide opportunities to study MS disease states with both central and peripheral demyelination, an aspect increasingly recognized in MS patients through magnetic resonance neurography techniques

    • Therapeutic testing: Testing antioxidant or mitochondrial-targeted therapies that might reduce neuronal damage and subsequent inflammation

  • Experimental approaches:

    • Longitudinal studies correlating oxidative damage with progression of neurological symptoms

    • Therapeutic interventions at different disease stages to determine windows for effective treatment

    • Comparative analysis with EAE models to distinguish immune-initiated versus neurodegeneration-initiated mechanisms

This model may be particularly valuable for studying the neurodegenerative aspects of MS that are less well represented in traditional EAE models.

What insights have SOD2 mouse models provided for cancer research and potential therapeutic strategies?

SOD2 mouse models have yielded valuable insights for cancer research:

  • Cancer susceptibility:

    • Sod2+/- mice show dramatically increased cancer incidence (83% tumor-bearing) compared to wild-type mice (41% tumor-bearing)

    • Particularly notable is the increased incidence of lymphoma (61% in Sod2+/- vs. 22% in wild-type)

    • This supports the hypothesis that chronic oxidative stress plays a causal role in carcinogenesis

  • Mechanistic insights:

    • Increased 8oxodG levels in both nuclear and mitochondrial DNA correlate with increased cancer incidence, supporting DNA damage as a key mechanism linking oxidative stress to carcinogenesis

    • Despite increased cancer incidence, the severity and proliferative activity of lymphomas were similar between Sod2+/- and wild-type mice, suggesting oxidative stress primarily affects cancer initiation rather than progression

  • Therapeutic implications:

    • These models support the potential value of antioxidant strategies specifically targeting mitochondrial superoxide for cancer prevention

    • The tissue-specific nature of cancer susceptibility suggests that certain tissues may be more vulnerable to oxidative stress-induced carcinogenesis

    • The dissociation between cancer incidence and aging phenotypes suggests that different mechanisms may link oxidative stress to these outcomes, requiring targeted therapeutic approaches

  • Research applications:

    • SOD2 mouse models can be used to test preventive strategies targeting mitochondrial oxidative stress

    • Combining SOD2 deficiency with carcinogen exposure or oncogene activation may provide more aggressive cancer models for therapeutic testing

    • Cross-breeding with tumor-suppressor-deficient mice can help elucidate interactions between oxidative stress and genetic cancer susceptibility

These models demonstrate that while oxidative stress clearly contributes to cancer development, the relationships between redox homeostasis, DNA damage, and carcinogenesis are complex and tissue-specific.

Product Science Overview

Introduction

Superoxide Dismutase-2 (SOD2), also known as manganese-dependent superoxide dismutase (MnSOD), is a crucial mitochondrial enzyme that plays a significant role in protecting cells from oxidative stress. This enzyme is encoded by the SOD2 gene and is a member of the iron/manganese superoxide dismutase family .

Structure and Function

SOD2 is a mitochondrial protein that forms a homotetramer, with each subunit binding one manganese ion. The enzyme’s active site contains a manganese ion that participates in the dismutation of superoxide radicals into hydrogen peroxide and molecular oxygen . This process is vital for mitigating the damaging effects of reactive oxygen species (ROS) produced during cellular respiration.

The SOD2 gene contains five exons and four introns, with a GC-rich promoter region that lacks the typical TATA or CAAT boxes. The proximal promoter region includes binding sites for various transcription factors, such as specific-1 (Sp1), activator protein 2 (AP-2), and early growth response 1 (Egr-1) .

Biological Significance

SOD2 is essential for maintaining cellular homeostasis by converting superoxide radicals, which are byproducts of oxidative phosphorylation, into less harmful molecules. This conversion helps prevent oxidative damage to cellular components, including DNA, proteins, and lipids . The enzyme’s activity is particularly crucial in tissues with high metabolic rates, such as the heart, liver, and brain.

Applications in Research and Medicine

Recombinant SOD2, particularly from mouse models, is widely used in research to study oxidative stress-related diseases and potential therapeutic interventions. Studies have shown that SOD2 plays a role in various pathological conditions, including idiopathic cardiomyopathy, premature aging, sporadic motor neuron disease, and cancer . Additionally, SOD2 has been investigated for its potential in anti-tumor, anti-radiation, and anti-aging therapies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.